DA Davidson raises Paysign stock price target to $15 on growth outlook

On Tuesday, investment firm DA Davidson increased its price target for Paysign Inc. (NASDAQ:PAYS) to $15.00, up from $12.00, while retaining a Buy rating for the shares. Currently, Paysign's stock is trading at $13.05, marking a remarkable 150% gain year-to-date, despite InvestingPro data suggesting potential overvaluation relative to its intrinsic value.

The price target elevation stems from DA Davidson's enhanced confidence in the company's growth prospects within the Patient Affordability niche, following multiple interactions with management over the past two months. The firm's revised outlook aligns with multiple analysts revising earnings upwards and projecting a year-over-year increase in net income.

In line with these positive assessments, DA Davidson has also revised its 2027 and introduced 2028 forecasts for Paysign. The upgraded price target and expanded forecasts underscore the firm's positive assessment of the company's growth potential.

Furthermore, Paysign Inc. recently reported strong second-quarter 2026 earnings, exceeding Wall Street estimates. The company reported earnings of $0.11 per share on revenue of $28.25 million, surpassing analyst expectations of $0.06 per share and $26.35 million in revenue. This performance marks the second consecutive quarter in which Paysign has surpassed expectations, showcasing consistent outperformance relative to market forecasts.

These developments reflect a promising trajectory for Paysign, with management highlighting the company's consistent ability to exceed analyst projections. The recent earnings report and positive outlook revisions position Paysign as a stock with substantial growth potential, as highlighted by its upgraded price target and expanded forecasts by DA Davidson.